Axilum Robotics’ Board of Directors is chaired by Pascal Neuville. Its members are Jean Briac Lesne, Jacques Lewiner, Benjamin Maurin, Marie-José Navarre and Pascal Neuville
Jean-Briac Lesne is associate at Inserm Transfert Initiative. He started his professional career in the Life Sciences Venture Capital team of Omnes Capital. Afterwards, he worked for Hyperion CD, an M&A and licensing advisory company dedicated to life sciences industries. In early 2015, he joined the management team of Inserm Transfert Initiative as analyst. Jean-Briac holds a Pharm.D. from Rennes University and graduated from ESCP-Europe Business School.
Jacques Lewiner is a scientist and an inventor. As a Scientific Director of ESPCI ParisTech in Paris, France, he worked with Pierre-Gilles de Gennes and created or contributed to the creation of numerous start-ups derived from research. Some of these start-ups have grown or are expanding rapidly. Jacques Lewiner was awarded the 2010 Prix de l’Ingénieur de l’année(Engineer of the Year Price) for his life’s work, by the French magazine Usine Nouvelle.
Benjamin Maurin is Co-founder and Technical and R&D Director at Axilum Robotics. After an experience as a consultant in motion control for industrial companies (GE Healthcare, Arc International), he joined the engineering department of Adept Technology as a senior engineer in robotics and real-time embedded software, contributing to the latest generation of Adept’s robot controllers. He brings more than 10 years of experience in robotics, vision and software development. Benjamin Maurin is graduated from Telecom Physique Strasbourg and holds a PhD in Robotics
Philibert d’HOTELANS has started his career at Institut Français du Petrole before joining the LOHR Group in 1979 in order to develop a new Food activity. Once this activity sold to FORGES INDUSTRIELLES DE STRASBOUG in 1982, he served as commercial manager at LOHR Defense during more than 15 years. From 1998 to 2012, he was appointed head of the Translohr branch, whose wheeled tramways have been installed in France, Italy, China and Columbia. After 5 years spent at NTL (subsidiary of ALSTHOM Transport), he joined again the LOHR Group in September 2017 as advisor of the President.
Philibert d’HOTELANS is graduated from Agro Paris Tech (ENSIA) and from CPA (MBA HEC).
Pascal Neuville is CEO of Domain Therapeutics. He owns a PhD in molecular biology from the University de Strasbourg, France. He spent five years at the University of Geneva, Switzerland, as a post doc and then as an Assistant Professor. Then Pascal joined Transgene where he was R&D project leader. From 2002 to 2008, he was CSO of Faust Pharmaceuticals, a drug discovery and development company in CNS. Pascal Neuville is a board member of Alsace BioValley, the life science competitiveness cluster of Alsace, France.
Raphaël DURAND started his career in JP Morgan Chanse and then Accenture. He joined thereafter multiple high growth companies in various sectors. He ran successfully several public and private fund raising and M&A operations. In 2014, he joined a MedTech company, Echosens, as CFO Group. He then set up and developed the US subsidiary, Echosens North America as CEO for this country. Today he is a Board Member and/or a Special Adviser for several innovative companies in the healthcare sector but also in the CleanTech field. He is graduated from ESSEC Business School (France).